Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CIFR vs GSK✓SelectedUSD · GSKCIFR vs GSK performance historyLatest closeAs of+2.34%11/18
Stock and ETF performance explorer

CIFR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+163.9%
GSK return
+56.0%
Excess return
+107.9%
Maximum drawdown
-81.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+2.3%-1.3%+3.7%+1.6%
7D-7.6%-3.1%-4.5%-9.1%
30D-26.5%-0.9%-25.6%-26.0%
3M-59.2%-4.2%-55.0%-59.3%
6M-65.6%-1.6%-64.0%-65.0%
YTD-55.5%+2.6%-58.1%-53.1%
1Y-54.9%+6.2%-61.2%-51.8%
All+163.9%+56.0%+107.9%+176.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling